Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans

Title
Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume -, Issue -, Pages -
Publisher
American Society for Clinical Investigation
Online
2018-07-25
DOI
10.1172/jci97911

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started